These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Myocardial infarction associated with antihypertensive drug therapy. Cooper RS; Freeman V JAMA; 1996 Feb; 275(7):515-6; author reply 516-7. PubMed ID: 8606467 [No Abstract] [Full Text] [Related]
6. Calcium channel blockers and myocardial infarction. A hypothesis formulated but not yet tested. Buring JE; Glynn RJ; Hennekens CH JAMA; 1995 Aug 23-30; 274(8):654-5. PubMed ID: 7637148 [No Abstract] [Full Text] [Related]
7. Overview of the safety of felodipine based on clinical trials in patients with hypertension. Welin L; Elvelin L; Niklasson A; Olsson G; Elmfeldt D Am J Cardiol; 1997 Apr; 79(7):996-9. PubMed ID: 9104926 [TBL] [Abstract][Full Text] [Related]
8. From the LSMS Committee on Chronic Diseases. Recent media reports of potential risks from calcium antagonists. Frohlich ED J La State Med Soc; 1995 Aug; 147(8):343. PubMed ID: 7673778 [No Abstract] [Full Text] [Related]
9. Calcium antagonists and cardiovascular events in patients with hypertension and diabetes. Alderman M; Madhavan S; Cohen H Lancet; 1998 Jan; 351(9097):216-7. PubMed ID: 9449897 [No Abstract] [Full Text] [Related]
10. Risk of myocardial infarction with combination antihypertensive regimens including a dihydropyridine calcium channel blocker in hypertensive diabetics. Anderson RJ; Alabi RA; Kelly WN; Diseker R; Roblin D J Manag Care Pharm; 2003; 9(1):29-35. PubMed ID: 14613359 [TBL] [Abstract][Full Text] [Related]
16. FDA approves i.v. calcium-channel blocker. Thompson CA Am J Health Syst Pharm; 2008 Sep; 65(18):1686. PubMed ID: 18768991 [No Abstract] [Full Text] [Related]
17. Calcium channel blocker use and gastrointestinal tract bleeding among older adults. Kaplan RC; Heckbert SR; Koepsell TD; Rosendaal FR; Furberg CD; Cooper LS; Psaty BM; Age Ageing; 2002 May; 31(3):217-8. PubMed ID: 12006312 [No Abstract] [Full Text] [Related]
18. Calcium-channel blockers and risk of myocardial infarction--more hype than harm. Phillips BG; MacFarlane LL; Carson DS Am J Health Syst Pharm; 1995 Jul; 52(13):1460-2. PubMed ID: 7671045 [No Abstract] [Full Text] [Related]
19. Study poses new questions about calcium-channel blockers. Jeffers ER Am J Health Syst Pharm; 1998 Apr; 55(8):762. PubMed ID: 9568234 [No Abstract] [Full Text] [Related]
20. Calcium antagonists should continue to be used for first-line treatment of hypertension. Epstein M Arch Intern Med; 1995 Nov; 155(20):2150-6. PubMed ID: 7487236 [No Abstract] [Full Text] [Related] [Next] [New Search]